← Leaderboards
Shiyou Chen
Harry S. Truman Memorial Va Hospital
$16,685,151
Attributed
$18,500,058
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,500,058 · 10
VA$0 · 1
By mechanism
R01$18,500,058 · 10
I01$0 · 1
Top collaborators
- Ken Fujise4 shared
- Bysani Chandrasekar1 shared
- Yusuke Higashi1 shared
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypePlayMolecularArteriesIn VivoSmooth Muscle MyocytesMediatingBlood VesselsLeadKnockout MiceCellsTissuesCardiovascular DiseasesLoss Of FunctionGenesProteinsGenetic ApproachSignal TransductionAttenuatedMouse ModelAffectNovel TherapeuticsAtherosclerosisTherapeutic Agents
Grant awards (42)
Targeting response gene to complement 32 to alleviate vascular remodeling$658,885
R01 · FY2025 · HL · contact PI
Novel Mechanisms underlying abdominal aortic aneurysm progression$651,122
R01 · FY2025 · HL · contact PI
RECK as a Therapeutic Target for Atherosclerosis$646,106
R01 · FY2025 · HL
Novel Mechanisms Underlying the Development of Atherosclerosis$0
I01 · FY2025 · VA · contact PI
Novel Mechanisms underlying abdominal aortic aneurysm progression$655,034
R01 · FY2024 · HL · contact PI
Novel Mechanisms Underlying the Development of Atherosclerosis$0
I01 · FY2024 · VA · contact PI
Cellular and Circulating Fortilin in Vascular Diseases$681,922
R01 · FY2023 · HL
ADAR1 in abdominal aortic aneurysm$570,648
R01 · FY2023 · HL · contact PI
Novel Mechanisms Underlying the Development of Atherosclerosis$0
I01 · FY2023 · VA · contact PI
Cellular and Circulating Fortilin in Vascular Diseases$683,899
R01 · FY2022 · HL
ADAR1 in abdominal aortic aneurysm$570,648
R01 · FY2022 · HL · contact PI
Dedicator of cytokinesis 2 in abdominal aortic aneurysm$523,201
R01 · FY2022 · HL · contact PI
Cellular and Circulating Fortilin in Vascular Diseases$683,899
R01 · FY2021 · HL
ADAR1 in abdominal aortic aneurysm$570,648
R01 · FY2021 · HL · contact PI
Dedicator of cytokinesis 2 in abdominal aortic aneurysm$523,201
R01 · FY2021 · HL · contact PI
Cellular and Circulating Fortilin in Vascular Diseases$718,619
R01 · FY2020 · HL
ADAR1 in abdominal aortic aneurysm$570,648
R01 · FY2020 · HL · contact PI
Dedicator of cytokinesis 2 in abdominal aortic aneurysm$523,201
R01 · FY2020 · HL · contact PI
Smad2 in vascular smooth muscle homeostasis$505,297
R01 · FY2020 · HL · contact PI
Dedicator of cytokinesis 2 in abdominal aortic aneurysm$523,201
R01 · FY2019 · HL · contact PI
Smad2 in vascular smooth muscle homeostasis$488,997
R01 · FY2019 · HL · contact PI
Smad2 in vascular smooth muscle homeostasis$488,997
R01 · FY2018 · HL · contact PI
Novel mechanism of smooth muscle phenotypic modulation and vascular remodeling$375,000
R01 · FY2018 · HL · contact PI
Dedicator of Cytokinesis 2 in smooth muscle phenotype modulation$353,726
R01 · FY2018 · HL · contact PI
Dedicator of Cytokinesis 2 in smooth muscle phenotype modulation$94,990
R01 · FY2018 · HL · contact PI
Smad2 in vascular smooth muscle homeostasis$488,997
R01 · FY2017 · HL · contact PI
Dedicator of Cytokinesis 2 in smooth muscle phenotype modulation$448,716
R01 · FY2016 · HL · contact PI
Novel mechanism of smooth muscle phenotypic modulation and vascular remodeling$375,000
R01 · FY2016 · HL · contact PI
Dedicator of Cytokinesis 2 in smooth muscle phenotype modulation$440,757
R01 · FY2015 · HL · contact PI
Novel mechanism of smooth muscle phenotypic modulation and vascular remodeling$368,349
R01 · FY2015 · HL · contact PI
Dedicator of Cytokinesis 2 in smooth muscle phenotype modulation$445,725
R01 · FY2014 · HL · contact PI
Novel mechanism of smooth muscle phenotypic modulation and vascular remodeling$372,500
R01 · FY2014 · HL · contact PI
Smooth Muscle Differentiation and Maturation$363,825
R01 · FY2014 · HL · contact PI
Smooth Muscle Differentiation and Maturation$353,430
R01 · FY2013 · HL · contact PI
Smad2 and Smooth Muscle Differentiation from Neural Crest Stem Cells$347,540
R01 · FY2013 · HL · contact PI
Smooth Muscle Differentiation and Maturation$371,250
R01 · FY2012 · HL · contact PI
Smooth Muscle Differentiation and Maturation$371,250
R01 · FY2011 · HL · contact PI
Smad2 and Smooth Muscle Differentiation from Neural Crest Stem Cells$368,750
R01 · FY2011 · HL · contact PI
Smad2 and Smooth Muscle Differentiation from Neural Crest Stem Cells$368,750
R01 · FY2010 · HL · contact PI
Smad2 and Smooth Muscle Differentiation from Neural Crest Stem Cells$356,400
R01 · FY2009 · HL · contact PI
Smad2 and Smooth Muscle Differentiation from Neural Crest Stem Cells$243,513
R01 · FY2009 · HL · contact PI
Smad2 and Smooth Muscle Differentiation from Neural Crest Stem Cells$353,417
R01 · FY2008 · HL · contact PI